← The Wire
MXCTNasdaq
MAXCYTE, INC.
Services-Commercial Physical & Biological Research · DE · CIK 1287098
MaxCyte provides cell engineering platform technologies for cell and gene therapies and research
red 8-K · 90d
$120M
Market cap
$1.24
Last close
0.0%
1D
+5.1%
5D
1.2M
Volume
Price · last 39 sessions+44.5%
May 4L $0.82 · H $1.27Jun 29
91
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 17, 20268-KDelisting NoticeJun 16, 2026SC 13DSC 13DMay 14, 202610-Q10-QMay 13, 20268-KResults of Operations · Reg FD DisclosureMay 12, 2026DEFA14ADEFA 14AApr 29, 2026DEF 14ADEF 14AApr 29, 20268-KExecutive ChangeMar 27, 202610-K10-KMar 25, 20268-KResults of Operations · Reg FD DisclosureMar 24, 20268-KDelisting NoticeMar 20, 20268-KResults of OperationsJan 12, 202610-Q10-QNov 13, 20258-KResults of Operations · Reg FD DisclosureNov 12, 20258-KResults of OperationsNov 5, 20258-KExit / Disposal Costs · Reg FD DisclosureSep 22, 20258-KExecutive ChangeAug 11, 202510-Q10-QAug 6, 20258-KResults of Operations · Reg FD DisclosureAug 6, 20258-KCompany UpdateJun 25, 20258-KExecutive Change · Shareholder VoteJun 18, 2025DEFA14ADEFA14AMay 29, 202510-Q10-QMay 8, 20258-KResults of Operations · Reg FD DisclosureMay 7, 2025DEF 14ADEF 14AApr 28, 202510-K10-KMar 11, 20258-KResults of Operations · Reg FD DisclosureMar 11, 20258-KReg FD DisclosureJan 30, 20258-KResults of OperationsJan 13, 20258-KExecutive Change · Reg FD DisclosureDec 27, 20248-KExit / Disposal Costs · Reg FD DisclosureDec 9, 202410-Q10-QNov 6, 20248-KResults of Operations · Reg FD DisclosureNov 6, 20248-KExecutive Change · Reg FD DisclosureOct 15, 202410-Q10-QAug 6, 20248-KResults of Operations · Reg FD DisclosureAug 6, 20248-KExecutive Change · Shareholder VoteJun 12, 202410-Q10-QMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 7, 2024DEF 14ADEF 14AApr 26, 2024SC 13GSC 13GMar 25, 202410-K10-KMar 12, 20248-KResults of OperationsMar 12, 20248-KResults of OperationsMar 5, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 13, 20248-KExecutive ChangeJan 26, 20248-KResults of OperationsJan 8, 20248-KExecutive Change · Reg FD DisclosureDec 11, 2023SC 13GSC 13GNov 17, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KResults of OperationsOct 4, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KExecutive Change · Shareholder VoteJun 23, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive Change · Reg FD DisclosureMar 28, 202310-K10-KMar 15, 20238-KResults of OperationsMar 15, 20238-KResults of OperationsMar 6, 20238-KExecutive Change · Reg FD DisclosureDec 1, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 9, 202210-Q10-QAug 10, 20228-KResults of OperationsAug 10, 20228-KExecutive Change · Shareholder VoteJun 30, 2022DEF 14ADEF14AMay 26, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 202210-K/AFORM 10-K/AApr 29, 20228-KExecutive Change · Results of OperationsApr 12, 202210-K10-KMar 22, 20228-KResults of OperationsMar 22, 2022SC 13GNONEFeb 15, 2022SC 13GSC 13GFeb 11, 2022SC 13GSC 13GFeb 4, 20228-KResults of OperationsJan 24, 2022
Insider Activity
In the 90 days to Mar 17, 2026: 1 sold $8K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Swirsky Douglas JCHIEF FINANCIAL OFFICER | Sell | 10,142 | $0.82 | $8K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance